Krvarenje iz tumora dojke kao hitno stanje u medicini

Nataša Čolaković; Simona Petričević

doi:10.5937/halo28-40727

Nataša Čolaković KBC Bežanijsak kosa
Simona Petričević KBC Bežanijska kosa

DOI: https://doi.org/10.5937/halo28-40727

Ključne reči: karcinom dojke; krvarenje; terapija;

Sažetak

Uvod: Karcinom dojke je najčešće maligno oboljenje kod žena. Godišnje oboli oko milion žena u svetu, sa kontinuiranim porastom incidence. Zahvaljujući napretku dijagnostike, uvođenju skrininga, hirurškom i onkološkom lečenju, karcinom dojke predstavlja dobro kontrolisanu bolest, a neretko i potpuno izlečivu. Međutim, još uvek se u kliničkoj praksi srećemo sa lokalno uznapredovalim oblicima ovog maligniteta. Česta komplikacija takvih ulcerisanih tumora je krvarenje koje predstavlja životno ugrožavajuće hitno stanje i koje se u najvećem broju slučajeva mora rešavati palijativnom hirurškom intervencijom. Cilj rada: Upoznati specijaliste urgentne medicine i lekare drugih specijalnosti sa opisanom komplikacijom, kako bi takve pacijente pravovremeno i na odgovarajući način zbrinuli. Metod rada: Pretražena je PubMed baza podataka i GoogleScholar i pronađeni su relevantni članci prema određenim ključnim rečima. Zaključak: Prepoznavanje krvarenja kao komplikacije i adekvatan hirurški tretman dovode do produžavanja preživljavanja i popravljanja kvaliteta života, čak i kada se radi i o bolesniku u terminalnom stadijumu maligne bolesti.

Reference

1. Mayo Foundation for Medical Education and Research [MFMER]. Breast Cancer. 2022. Dostupno na: https://www.mayoclinic.org/diseases-conditions/breast-cancer/symptoms-causes/syc-20352470

2. World Health Organization. Breast Cancer. 2021. Dostupno na: https://www.who.int/news-room/fact-sheets/detail/breast-cancer#:~:text=a%20breast%20lump%20or%20thickening,abnormal%20nipple%20discharge

3. Institut za javno zdravlje Srbije “Dr Milan Jovanović Batut”. Окtоbаr - mеđunаrоdni mеsеc bоrbе prоtiv rака dојке. 2021. Dostupno na: https://www.batut.org.rs/index.php?content=2279

4. Anđelković M, Djordjevic AB, Miljaković EA, Javorac D, Čolaković N, Oprić S, Petričević S, Granić M, Kotur-Stevuljević J, Antonijević B, Bulat Z. Cadmium tissue level in women diagnosed with breast cancer - A case control study. Environ Res. 2021 Aug;199:111300. doi:10.1016/j.envres.2021.111300. Epub 2021 May 18. PMID: 34015299.

5. Cancer Treatment Centers of America [CTCA].What are the signs and symptoms of breast cancer? 2022. Dostupno na: https://www.cancercenter.com/cancer-types/breast-cancer/symptoms

6. Stephens F, Harker GS, Crea P, Roberts B, Hambly C. Intra-arterial chemotherapy as basal treatment in advanced and fungating primary breast cancer. The Lancet 1980; Aug 30;316[8192]:435-8.

7. Pagani O, Senkus E, Wood W, Colleoni M, Cufer T, Kyriakides S, Costa A, Winer EP, Cardoso F; ESO-MBC Task Force. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst. 2010 Apr 7;102(7):456-63. doi:10.1093/jnci/djq029. Epub 2010 Mar 10. PMID: 20220104; PMCID: PMC3298957.

8. Johnstone C, Rich SE. Bleeding in cancer patients and its treatment: a review. Annals of palliative medicine 2017; Dec 18;7[2]:265-73.

9. Schneider BP, Miller KD. Angiogenesis of breast cancer. Journal of Clinical Oncology 2005; 23[8]:1782-90.

10. Naoyo N, Hirohisa Y, Takashi N, Toshiharu K, Masamichi K. Angiogenesis in cancer. Vasc Health Risk Manag 2006; 2[3]:213-9.

11. Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cellular and Molecular Life Sciences 2020; May;77[9]:1745-70.

12. Piran S, Schulman S. Treatment of bleeding complications in patients on anticoagulant therapy. Blood 2019; Jan 31;133(5):425-435. doi: 10.1182/blood-2018-06-820746. Epub 2018 Dec 17. PMID: 30559261.

13. McMahon P, Reichman M, Dodelzon K. Bleeding risk after percutaneous breast needle biopsy in patients on anticoagulation therapy. Clin Imaging 2021; Feb;70:114-117. doi:10.1016/j.clinimag.2020.09.014. Epub 2020 Oct 7. PMID: 33157367.

14. Goodwin A, Parker S, Ghersi D, Wilcken N. Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD000563. doi:10.1002/14651858.CD000563.pub4. Update in: Cochrane Database Syst Rev. 2009;(3):CD000563.PMID: 19160183.

15. Zdravkovic D, Petricevic S, Toskovic B. Influence of different response after neoadjuvant chemotherapy on time of surgery in breast cancer patients. Breast Cancer Res Treat 2021;May;187(1):299. doi: 10.1007/s10549-021-06161-3. Epub 2021 Mar. PMID: 33661438.

16. Čolaković N, Čolaković G. Dijagnostika i terapija urgentnih stanja kod onkoloških bolesnika. Halo 194. 2018;24(2):126-36. doi: 10.5937/Halo1802126C

17. Firmino F, Villela-Castro DL, Santos JD, Conceição de Gouveia Santos VL. Topical Management of Bleeding From Malignant Wounds Caused by Breast Cancer: A Systematic Review. J Pain Symptom Manage. 2021 Jun;61(6):1278-1286. doi: 10.1016/j.jpainsymman.2020.10.020. Epub 2020 Oct 20.PMID: 33096218.

18. Milenkovic M, Hadzibegovic A, Kovac M, Jovanovic B, Stanisavljevic J, Djikic M, Sijan D, Ladjevic N, Palibrk I, Djukanovic M, Velickovic J, Ratkovic S, Brajkovic M, Popadic V, Klasnja S, Toskovic B, Zdravkovic D, Crnokrak B, Markovic O, Bjekic-Macut J, Aleksic A, Petricevic S, Memon L, Milojevic A, Zdravkovic M. D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia. Oxid Med Cell Longev 2022; Feb 28;2022:8997709.doi: 10.1155/2022/8997709. PMID: 35237386; PMCID: PMC8884120.